Pharmafile Logo
- PMLiVE

Pharmaceutical Market Europe – May 2017

In the May issue of PME we look at patient engagement and hear how some of the structural barriers within the industry are working against some of its initiatives

- PMLiVE

Pharmaceutical Market Europe – April 2017

As Brexit begins, the April issue of PME offers advice on what pharma should do next and how the likely timelines shapeup

- PMLiVE

Pharmaceutical Market Europe – March 2017

This month in PME we take a look at employee engagement and the crucial role it plays in attracting and retaining talent, with those companies that get it right reaping...

- PMLiVE

Pharmaceutical Market Europe – February 2017

In the February issue of PME we look to balance the changes that are already the theme of 2017 with some much needed stability.

- PMLiVE

Pharmaceutical Market Europe – January 2017

The January issue of PME kicks off 2017 by analysing some of the seismic changes that are affect the industry over the next 12 months and beyond.

- PMLiVE

Pharmaceutical Market Europe – December 2016

This month we hear from the European Commissioner for Health on the burden European countries face from chronic diseases.

- PMLiVE

Pharmaceutical Market Europe – November 2016

This month we place behavioural change under the spotlight in a special section, where our expert contributors offer their thoughts on areas such as translating the theory into practice, applying...

- PMLiVE

Pharmaceutical Market Europe – October 2016

There’s no shortage of ambition at GlaxoSmithKline, whose chief immunology officer and senior vice president of their R&D pipeline Paul-Peter Tak we spoke to for this month’s executive interview.

- PMLiVE

Pharmaceutical Market Europe – September 2016

How confident are you in your country’s healthcare system? It’s the central issue for this month’s cover feature, which focuses on a global study of healthcare perceptions and offers up...

- PMLiVE

Pharmaceutical Market Europe – July/August 2016

Generating customer value, biosimilars, Brexit implications and immunotherapy directions

- PMLiVE

Pharmaceutical Market Europe – June 2016

Diversification, Brexit, rare diseases and the power of brand creativity

- PMLiVE

Pharmaceutical Market Europe – May 2016

The time for change is now, as our cover feature on medical affairs puts it, but there’s a transitional theme to much of this month’s PME